Applied Dna Scns (APDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 2,054 | 779 | 884 | 1,195 | 1,016 |
| Cost of Goods | 271 | 133 | 154 | 251 | 253 |
| Gross Profit | 1,783 | 645 | 731 | 945 | 764 |
| Operating Expenses | 3,485 | 3,411 | 4,081 | 4,661 | 3,883 |
| Operating Income | -1,432 | -2,633 | -3,196 | -3,465 | -2,866 |
| Interest Expense | 38 | 37 | 0 | 0 | 0 |
| Other Income | -8 | -17 | -38 | -10 | -21 |
| Pre-tax Income | -1,478 | -2,687 | -3,234 | -3,475 | -2,888 |
| Net Income Continuous | -1,478 | -2,687 | -3,234 | -3,475 | -2,888 |
| Net Income | $-1,478 | $-2,687 | $-3,234 | $-3,475 | $-2,888 |
| EPS Basic Total Ops | -31.00 | -64.40 | -85.00 | -85.20 | -80.00 |
| EPS Basic Continuous Ops | -31.02 | -64.35 | -84.89 | -91.35 | -76.72 |
| EPS Diluted Total Ops | -31.00 | -64.40 | -85.00 | -85.20 | -80.00 |
| EPS Diluted Continuous Ops | -31.02 | -64.35 | -84.89 | -91.35 | -76.72 |
| EBITDA(a) | $-1,340 | $-2,530 | $-3,057 | $-3,342 | $-2,743 |